The Lancet Group

The Lancet Haematology in conversation with

Join the editors of The Lancet Haematology as they discuss groundbreaking research with authors, tackling vital health issues and their implications for policy and care.

Listen on Apple Podcasts

Michael Northend on early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma

16 mins • Apr 28, 2025

Recent Episodes

Apr 28, 2025

Michael Northend on early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma

16 mins

Mar 31, 2025

Joanne Verweij and Romy Pothof on fetal and neonatal alloimmune thrombocytopenia

18 mins

Mar 3, 2025

Helene Schoemans, Elke Stienissen, and Kathy Goris on a consulting a patient advisory board to understand unmet needs of patients with GVHD in Europe

27 mins

Jan 29, 2025

Dawn Swan on air pollution and venous thromboembolism

15 mins

Jan 16, 2025

Leslie Skeith on low-dose aspirin for postpartum venous thromboembolism prophylaxis

16 mins

Language
English
Country
United States
Feed Host
Request an Update
Updates may take a few minutes.